Related Experiment Video
Updated: May 20, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
In this issue: harnessing immunity against difficult targets, through the CD40-CD40L pathway
International Reviews of Immunology
|July 19, 2012
Summary
The CD40-CD40L pathway is a key regulator of immune responses, showing promise in cancer and infectious disease treatments. This review explores strategies for developing new therapies targeting this pathway for improved immune interventions.
Area of Science:
- Immunology
- Oncology
- Translational Medicine
Background:
- The CD40-CD40L pathway acts as a crucial link between innate and adaptive immunity.
- This pathway is pivotal for immune cell activation and function.
Discussion:
- Explores direct CD40 targeting on tumor cells and antigen-presenting cell (APC) licensing.
- Discusses in vivo immune effector activation and adoptive cell transfer strategies.
- Highlights the versatility of CD40 agonistic engagement for therapeutic development.
Key Insights:
- The CD40-CD40L pathway demonstrates significant translational potential in oncology and infectious diseases.
- Diverse therapeutic strategies can be designed by targeting this master immune-switch.
- Combinatorial therapies involving CD40 agonistic engagement offer novel treatment options.
Outlook:
- Future research should focus on designing safe and effective immune interventions targeting CD40.
- Advancing novel therapies requires a comprehensive understanding of CD40 pathway modulation.
- The development of CD40-based treatments holds promise for various immunological conditions.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:40Cell-mediated Immune Responses
Overview
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.